“…Leukocyte‐ and platelet‐rich fibrin (L‐PRF) has been investigated as a promising autologous source of cytokines and growth factors that favor tissue regeneration (Choukroun et al, ; Choukroun et al, ; Dohan Ehrenfest et al, ; He, Lin, Hu, Zhang, and Wu, ; Kang et al, ; Simonpieri et al, ; Ghanaati et al, ; Zhao et al, ). In clinical practice, L‐PRF has been applied in different areas that seek excellence for the healing processes of soft and hard tissues (Braccini and Dohan, ; Chang et al, ; Eren, Tervahartiala, Sorsa, and Atilla, ; Eshghpour et al, ; Canellas et al, ; Somani and Rai, ). Initially described by Choukroun, Adda, Schoeffler, and Vervelle () in France, L‐PRF is considered a second‐generation platelet concentrate and is characterized as a true autologous healing matrix (Choukroun et al, ; Dohan et al, ).…”